CDK9-IN-26
CDK9-IN-26 (compound 1is a CDK9 inhibitor (IC50=0.18 μM) . [1].
Product Specifications
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-26.html
Solubility
10 mM in DMSO
Smiles
COC1=CC=C(NC2=C(C3=COC=C3)N=C4C=NC=CN42)C=C1
Molecular Formula
C17H14N4O2
Molecular Weight
306.32
References & Citations
[1]Alsfouk AA, et al. New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches. Pharmaceuticals (Basel) . 2023 Jul 18;16 (7) :1018.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
